News Focus
News Focus
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: volgoat post# 246491

Wednesday, 12/23/2015 9:44:55 AM

Wednesday, December 23, 2015 9:44:55 AM

Post# of 347009
volgoat, if they want to PR the full enrolment of SUNRISE then the CA will NOT keep them from doing so.

What would that PR say so much differently as what they already told us last CC. They have the needed patients. Period, that is all we needed to know because THAT constituted a RISK in our shareholders book. The Risk to not being able to find the patients in a decent time frame.

All RISK related to running the clinical trial are thereby GONE as explained and listed in this linked post chain.

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y